Skip to main content
. Author manuscript; available in PMC: 2010 May 14.
Published in final edited form as: J Med Chem. 2009 May 14;52(9):2846–2853. doi: 10.1021/jm801643b

Table 1.

Binding parameters, inhibitory potencies and antiparasitic effects of selected TCCYP51 ligands

Compound Spectral Response in TCCYP51
Effect on enzymatic activity (I/E2****)
Type Soret band maximum, nm Kd, μM TCCYP51 Mouse COX2

5 2 422 0.44±0.02 10

7 2 422 0.75±0.03 14
9 2 422 0.24±0.01 <1

12 2 422 0.29±0.01 9.1 2.1
13 2** 418 7.6±0.9 13 >10
14 2 422 0.54±0.02 10 10
15 2 422 0.37±0.05 8.5 1.7
16 1* 416 3.3±0.48 11 2.1
17 none 417 - 15 3.6
19 2** 420 0.56±0.08 7.7 <1
18 2** 420 0.26±0.04 4.2 <1
20 2*** 422 2.31±0.09 6.3 2.4
21 2** 419 0.36±0.02 <1 <1
22 2** 419 0.15±0.01 <1 >40
*

weak type 1 response with only ~7% of P450 experiencing low to high spin transition;

**

modified type 2 response with the smaller shift in the Soret band maximum,

***

sigmoid curve, Hill coefficient 2.3±0.2 (see Figure 2);

****

inhibitory potencies of the compounds toward TCCYP51 (minimal final concentration required in the reconstituted reaction 1 μM9) and mouse COX2 (final concentration 0.1 μM) are compared as molar ratios Inhibitor/Enzyme which cause a two-fold decrease in the initial rate of catalysis.